Citadel Advisors’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-21,603
| Closed | -$64K | – | 4470 |
|
|
2016
Q3 | $64K | Sell |
21,603
-451
| -2% | -$1.34K | ﹤0.01% | 3261 |
|
|
2016
Q2 | $33K | Sell |
22,054
-19,047
| -46% | -$28.5K | ﹤0.01% | 3120 |
|
|
2016
Q1 | $152K | Buy |
41,101
+24,674
| +150% | +$91.3K | ﹤0.01% | 2787 |
|
|
2015
Q4 | $166K | Sell |
16,427
-14,168
| -46% | -$143K | ﹤0.01% | 3041 |
|
|
2015
Q3 | $416K | Sell |
30,595
-97,289
| -76% | -$1.32M | ﹤0.01% | 2723 |
|
|
2015
Q2 | $2.43M | Buy |
127,884
+23,109
| +22% | +$438K | ﹤0.01% | 1624 |
|
|
2015
Q1 | $2.74M | Buy |
104,775
+91,898
| +714% | +$2.4M | ﹤0.01% | 1590 |
|
|
2014
Q4 | $270K | Buy |
12,877
+9,426
| +273% | +$198K | ﹤0.01% | 2918 |
|
|
2014
Q3 | $115K | Sell |
3,451
-98,496
| -97% | -$3.28M | ﹤0.01% | 3040 |
|
|
2014
Q2 | $3.27M | Buy |
101,947
+37,628
| +59% | +$1.21M | ﹤0.01% | 1262 |
|
|
2014
Q1 | $2.97M | Buy |
64,319
+36,786
| +134% | +$1.7M | ﹤0.01% | 1284 |
|
|
2013
Q4 | $1.95M | Buy |
27,533
+24,944
| +963% | +$1.77M | ﹤0.01% | 1368 |
|
|
2013
Q3 | $222K | Sell |
2,589
-11,862
| -82% | -$1.02M | ﹤0.01% | 2261 |
|
|
2013
Q2 | $915K | Buy |
+14,451
| New | +$915K | ﹤0.01% | 1712 |
|